JSE Slide Continues as Sibanye Strike Looms; Aspen and Motus Lift Sentiment

The JSE extended its losing run on Wednesday, with the All Share closing 0.67% lower and the broader market painting red across most sectors. Health Care was the standout casualty — dragged by Pharmaceuticals' 7.35% slide — while Industrials fell 1.45% and the Top 40 shed 0.58%. Energy managed a rare positive close at +0.73%, but it was not enough to offset the broad-based sell-off that left the FTSE/JSE Technology and Electronic & Electrical Equipment indices at the bottom of the board. Against that backdrop, two of the day's major results — Aspen Pharmacare and Motus Holdings — delivered positive prints, offering pockets of relief for investors navigating a difficult session.

Sibanye Stillwater — Strike notice puts cash-negative US PGM operation on existential footing

Sibanye Stillwater has received a strike notice covering Stillwater East mine and the Columbus metallurgical facility, effective 3 September 2026. The stoppage affects roughly 55% of US platinum group metal production and lands on an operation already running at a negative notional free cash flow margin in the first half of 2026. More than four months of collective bargaining have failed to close the gap between management and the union on a redesigned performance and incentive plan. East Boulder mine is excluded from the notice and continues operating under a separate agreement, providing partial insulation.

The CEO has placed the stakes plainly on record: if the transformation plan cannot be implemented, there may ultimately be no viable basis for the continued operation of the US PGM segment. That language — from management itself — elevates this beyond a routine labour dispute into a structural viability question. The strike's duration and whether a resolution can be found at East Boulder will be the critical near-term determinants.

The share had run up 24.8% over the 20 trading days prior to Wednesday's SENS disclosure, meaning a meaningful portion of the market had already priced a positive labour outcome. Any further news on strike duration or mediation progress will be closely watched by investors assessing whether the US PGM restructuring story has a future.

APN Aspen confirms FY2026; FY2027 normalised EBITDA target set at R9bn

Aspen Pharmacare's full-year results landed in line with its August trading statement, confirming normalised EBITDA growth of 14% in constant exchange rate terms and normalised HEPS of 801.5 cents per share. The dividend was raised 10% to 232 cents per share, set at 20% of normalised HEPS and aligned to the group's capital allocation framework. Free cash flow of R3.8 billion marginally cleared the R3.7 billion guided figure, with operating cash conversion well above 100%.

The fresh signal for investors is the FY2027 normalised EBITDA guidance of at least R9 billion in constant currency — a figure that was not included in the prior trading statement. The group expects Manufacturing EBITDA to more than double relative to FY2026, and net interest savings of approximately R1.2 billion underpin the outlook. Commercial Pharmaceuticals revenue grew 5% to R25.4 billion in constant currency, led by strong demand for Mounjaro in South Africa.

The headline HEPS decline of 20% reflects R2.3 billion of restructuring charges and a further R2.3 billion of intangible impairments driven by higher discount rates — real costs that weigh on reported earnings. However, the normalised measures stripped of those items show a business tracking well, and the forward EBITDA target gives the market a concrete benchmark to monitor through FY2027.

MTH Motus delivers HEPS up 15%, dividend up 29% and ROIC above WACC

Motus Holdings closed its financial year with headline earnings per share rising 15% to 1,777 cents, while profit before tax climbed 20% to R4.0 billion on the back of a 19% reduction in net finance costs. The total dividend was lifted 29% to 710 cents per share, with the payout ratio extended from 35% to 40% of HEPS — a meaningful signal of confidence from the board in the sustainability of earnings.

The balance sheet metrics are the strongest part of this print. Net debt to EBITDA improved to 1.3 times, and EBITDA to net interest covered 5.4 times — both comfortably inside covenant thresholds. Return on invested capital rose to 12.6%, sitting 3 percentage points above the group's WACC of 9.4%, which indicates that Motus is deploying capital at a premium to its cost. Cash generated from operations rose 6% to R7,990 million.

The second half did decelerate from the interim period's 19% HEPS growth, and international operations lagged: UK Aftermarket Parts margin compressed from 13.0% to 11.6% due to minimum wage and national insurance cost pressures, while Australia Retail was subdued. No explicit FY2027 financial guidance was provided, leaving the market to assess sustainability from here. Investors will look to the next trading statement for evidence that the double-digit earnings trajectory can be maintained.

CSB Cashbuild revenue up 6% but HEPS falls 9% and final dividend cut 22%

Cashbuild grew revenue 6% to R12.1 billion over the year ended 28 June 2026, but operating profit fell 15% as operating expenses rose 9% — or 7% excluding Malawi — reflecting cost pressures that were not fully recovered through pricing. Headline earnings per share declined 9%, and the board responded with a 22% cut to the final dividend, bringing it to 233 cents per share. The full-year dividend was held flat only because the interim dividend was larger, meaning back-half earnings cover weakened materially through the year.

Cash and short-term funds did increase 4% to R2.0 billion, providing a stronger liquidity position, but the margin-compression picture is a concern for a business that had been growing steadily. Management itself flagged that trading conditions are expected to remain challenging, adding a cautious forward note to a result that had already seen the share sell off 9.4% in the 20 trading days ahead of Wednesday's SENS release. The full annual report will be needed to show whether operating cash flow backs the R196 million headline earnings figure and which part of the estate drove the operating profit decline.

WHL Woolworths meets FY26 guidance but H2 deterioration weighs on outlook

Woolworths delivered HEPS of 282.3 cents per share for the 52 weeks ended 28 June 2026, up 5.3% and within the 274.8 to 288.2 cent guidance range it set on 30 July. Adjusted diluted HEPS of 314.7 cents cleared the midpoint of its range. Group sales grew 3.3% in the second half, but management described the final quarter as particularly challenging, and the Fashion, Beauty and Home division bore the brunt: aEBIT fell 14.1% to R1,375 million with 130 basis points of gross margin compression to 46.0%.

The impairment rate at Woolworths Financial Services rose to 7.0% from 6.1%, with the issuer attributing this to a deteriorating macroeconomic environment in the second half. Country Road Group returned to full-year profitability with aEBIT of A$2.3 million and gross margin expanding 130 basis points to 57.7%, providing one bright spot. Food delivered above-market growth of 5.7% while holding gross margin flat at 24.9%, even as fuel-driven distribution costs increased.

Cash conversion jumped to 104.5% from 82.5%, generating free cash flow of 449.4 cents per share, and ROCE improved to 17.0% from 16.4%. The share had already sold off 10.4% in the 20 days before Wednesday's results, so the H2 deterioration was not arriving cold. The absence of FY2027 guidance and the lack of quantified cost-saving targets mean the market still lacks a clear view on whether the FBH margin reset has bottomed out.

TFG Group sales up 0.2% in ZAR; Africa resilient, Australia remains a drag

The Foschini Group reported group sales growth of 0.2% in rand terms (2.0% in constant currency) to R23 billion for the 21 weeks ended 22 August 2026. TFG Africa accelerated to 3.4% sales growth on a like-for-like basis of 1.5%, gaining 10 basis points of South African market share per RLC data, while TFG London delivered 2.3% sterling sales growth. The standout was online: group online penetration stepped up to 15.9% from 13.8%, and TFG Africa's Bash platform surged 54.1% — a structural mix shift that the group is building around.

The headwind came from TFG Australia, where sales fell 4.7% in Australian dollars on a like-for-like basis of negative 4.1%, in what management described as the toughest trading environment it has faced. The ongoing Tarocash brand repositioning further compounded the sales pressure in Australia. TFG Africa's credit sales contracted 2.5% and their share of total sales fell to 26.0% from 27.5%, pointing to ongoing discretionary spending stress among its customer base.

The group plans approximately 80 further TFG Africa store closures in FY2027, adding to the 85 unviable stores already closed versus 25 opened. The store-closure programme and the accelerating online contribution are the structural positives, but the market will need evidence from the interim results that these actions are translating into improved margin and return on capital before the name can be re-rated.

HMN Hammerson prices £250m bond four times covered, pre-funding June 2027 maturity

Hammerson priced a £250 million seven-year bond at a coupon of 5.875%, with demand exceeding £1.1 billion — more than four times covered at launch. The proceeds build cash ahead of the EUR700 million sustainability-linked bond maturing in June 2027, on top of the £500 million the group already held at 30 June 2026. The bond was swapped to a floating rate with a net initial cost of 5.04%, and the group's fixed-rate debt proportion drops from 95% to 84%, leaving 16% of gross debt exposed to SONIA movements.

Investment-grade ratings were maintained: BBB+ issuer default with stable outlook from Fitch and Baa1 from Moody's, with the new bond expected to be rated A minus and Baa1 respectively. This is a credit-positive execution on a previously disclosed funding plan — the market had already seen the supplementary prospectuses and half-year results that flagged the refinancing need.

The new bond's 5.04% net initial rate is a material step up from the 1.75% coupon on the EUR700 million June 2027 bond it is pre-funding, and the £250 million raised is materially smaller than the EUR700 million gap still to be closed. The refinancing story is therefore progressing on good terms, but the full picture — and the question of at what blended cost the remaining maturity is addressed — remains open for investors to track.

What we are watching

Several AGMs and pre-close events are scheduled for the near term. Fairvest will host its pre-close and operational update conference call on 22 September 2026, ahead of its 30 September year-end. Tharisa may provide a pricing update on its contemplated USD 300 million senior secured bond — any confirmation of pricing and terms would give investors a signal on Karo Platinum Mine capex funding. The Hammerson bond swap completion and any further disclosure on the EUR700 million refinancing plan will also be monitored.